AP NEWS

Global Central Nervous System Partnering Analysis 2012-2018: Updated Deal Trends, Players and Financials - ResearchAndMarkets.com

October 3, 2018

DUBLIN--(BUSINESS WIRE)--Oct 3, 2018--The “Global Central Nervous System Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering.

Global Central Nervous System Partnering 2012 to 2018 provides the full collection of Central Nervous System disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Central Nervous System disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Central Nervous System deals.

The report presents financial deal terms values for Central Nervous System deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope

Trends in Central Nervous System dealmaking in the biopharma industry since 2012 Analysis of Central Nervous System deal structure Access to headline, upfront, milestone and royalty data Access to hundreds of Central Nervous System deal contract documents Comprehensive access to over 3500 Central Nervous System deal records The leading Central Nervous System deals by value since 2012 Most active Central Nervous System dealmakers since 2012

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Central Nervous System dealmaking

Central Nervous System partnering over the years Central Nervous System partnering by deal type Central Nervous System partnering by industry sector Central Nervous System partnering by stage of development Central Nervous System partnering by technology type Central Nervous System partnering by therapeutic indication

Chapter 3 - Financial deal terms for Central Nervous System partnering

Disclosed financials terms for Central Nervous System partnering Central Nervous System partnering headline values Central Nervous System deal upfront payments Central Nervous System deal milestone payments Central Nervous System royalty rates

Chapter 4 - Leading Central Nervous System deals and dealmakers

Most active in Central Nervous System partnering List of most active dealmakers in Central Nervous System Top Central Nervous System deals by value

Chapter 5 - Central Nervous System contract document directory

Central Nervous System partnering deals where contract document available

Chapter 6 - Central Nervous System dealmaking by therapeutic target

Deals by Central Nervous System therapeutic target

Appendices

Appendix 1 - Directory of Central Nervous System deals by company A-Z 2012 to 2018

Appendix 2 - Directory of Central Nervous System deals by deal type 2012 to 2018

Appendix 3 - Directory of Central Nervous System deals by stage of development 2012 to 2018

Appendix 4 - Directory of Central Nervous System deals by technology type 2012 to 2018

For more information about this report visit https://www.researchandmarkets.com/research/n24xhv/global_central?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181003005421/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/03/2018 07:12 AM/DISC: 10/03/2018 07:12 AM

http://www.businesswire.com/news/home/20181003005421/en

AP RADIO
Update hourly